Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted by the Regulatory Affairs Professional Society in “FDA Expresses Desire to Work with Industry on CGMPs for Combo Products,” by Zachary Brousseau.
Following is an excerpt:
An audio recording of the workshop is also provided. Mr. Thompson's comments start circa 5:00.